Sharing-our-perspective-page-header2



Sharing perspectives leads to greater understanding and fuels innovation. The ​Optum Insights ​blog is where we share our perspective and challenge preconceptions to clear a new path forward


  • The coming Texas compound preauthorization requirement: Attention to grandfathered prescriptions

    by
    • Optum for Workers' Compensation
    | Jun 12, 2018
    Tag Icon
    Workers' Compensation, Compounded Medications
    The Texas Division of Workers’ Compensation adopted changes to its Closed Formulary to require preauthorization for all compounded medications, regardless of ingredient makeup. The new preauthorization requirement takes effect for prescriptions written and dispensed on or after July 1, 2018.


  • Drug Recall: Two lots of Naloxone injection recalled

    by
    • Optum Workers' Comp
    | Jun 06, 2018
    Tag Icon
    Workers' Compensation, Naloxone, FDA
    The U.S. Food and Drug Administration (FDA) announced that Hospira, Inc., a Pfizer company, voluntarily recalled two lots of naloxone hydrochloride injection at the hospital and institution level. Naloxone injection is used in the emergency treatment of a known or suspected opioid overdose. However, this recall does not affect the naloxone products Evzio® auto-injector or Narcan® Nasal Spray.


  • Kentucky initiates formulary development

    by
    • Optum for Workers' Compensation
    | Jun 05, 2018
    Tag Icon
    Workers' Compensation, formulary
    In response to House Bill 2, the Kentucky Workers’ Compensation Medical Advisory Committee met on May 31 to review the recently signed workers’ compensation reform legislation. Commissioner Robert Swisher gave an overview of the new legislative mandates, including adoption of a drug formulary and additional medical treatment guidelines, and plans for moving forward for regulatory development.


  • Tennessee enacts enhanced opioid prescribing controls

    by
    • Optum Workers' Comp
    | Jun 01, 2018
    Tag Icon
    Opioids
    House Bill 1831 was recently signed by Tennessee’s Governor, which enacts prescribing restrictions on opioid analgesics; sets dose caps on morphine milligram equivalent (MME); and defines enhanced prescription drug monitoring program (PDMP) requirements. Effective July 1, 2018, the bill bases prescribing restrictions on various treatment timeframes and requires the prescriber to properly examine, justify and document the need for additional opioid treatment.


  • Louisiana expands use of medical marijuana

    by
    • Optum Workers' Comp
    | May 31, 2018
    Tag Icon
    Medical Marijuana
    The Louisiana Legislature, in the waning days of their session, approved House Bill 579 permitting usage of medical marijuana to treat an expanded list of conditions. The bill permits medical marijuana to treat conditions such as glaucoma, muscle spasms, post-traumatic stress disorder (PTSD), Parkinson’s disease and intractable pain.


  • DFEC clarifies reimbursement policies on physician dispensed medications

    by
    • Optum Workers' Comp
    | May 29, 2018
    Tag Icon
    Workers' Compensation, Physician Dispensing


  • Colorado moves to curb opioid utilization

    by
    | May 24, 2018
    Tag Icon
    Workers' Compensation, Pain Management, PDMPs, Opioids
    Recently, Colorado’s Governor signed into law Senate Bill 22, which enacts opioid prescribing restrictions as well as enhanced PDMP reviewing/reporting requirements. The bill also requires that the PDMP program develop and provide prescribers of opioids a “health care provider report card” related to their prescribing patterns.



Stay informed by receiving latest updates

Do you have a question about a blog post?